|
Dow Jones Futures: Tesla, Nvidia Lead 7 Stocks In Buy Zones; Bitcoin Soars As Coinbase IPO Looms Investor's Business DailyS&P 500 closes at record, Nasdaq adds 1% as stocks shake off J&J vaccine halt, higher inflation CNBCStock market news live updates: Stocks mixed after US officials call for pause of J&J vaccine rollout Yahoo FinanceThe 24 Least-Loved Stocks in the S&P 500, and Why You Should Buy Them Barron's
|
RELATED ARTICLES | | |
|
Shares of the digital marketing firm fell in spite of a strong second-quarter update.
|
RELATED ARTICLES | | |
|
 The S&P 500 finished at a record and technology shares closed in the green Tuesday as long-term government bond yields retreated despite data showing a surge in consumer prices in March. Investors were hit with early negative headlines after the Food and Drug Administration and the Centers for Disease Control and Prevention requested the immediate halt in the use of Johnson & Johnson's one-shot COVID vaccine out of "an abundance of caution" due to extremely rare blood-clotting issues in women. That report was followed by a highly anticipated reading of March that showed U.S. consumer prices rising on the month for the fourth month in a row, with the pace of inflation hitting the highest level in 21/2 years. The rate of inflation over the past year shot up to 2.6% from 1.7% in the prior month, marking the highest level since the fall of 2018. The S&P 500 closed at a record at around 4,141, about 0.3% higher, while the Nasdaq Composite Index closed up 1.1% as technology shares scored a bounce off reteating bond yields. The 10-year Treasury note yielded 1.62% , with the decline following the CPI report, which some traders said wasn't as hot as expected, helping support some bids for long-dated bonds and relieving some of the pressure of higher borrowing costs on investments viewed as speculative like tech and tech-related shares. The Dow Jones Industrial Average , however, closed off 0.2% at aroound 33,677.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
|
|
The global tally for the coronavirus-borne illness rose above 136.7 million on Tuesday, according to data aggregated by Johns Hopkins University, as the death toll climbed above 2.94 million. The U.S. leads the world in cases and deaths by wide margins, with 31.3 million cases, or about 23% of the global total, while the 562,533 death toll make of about 19% of the global toll. The U.S. added at least 72,286 new cases and 476 new deaths on Monday, according to a New York Times tracker. The U.S. has averaged 69,030 cases per day in the past week, up 6% from the average two weeks ago. The rise in new cases comes despite the continued increase in vaccinations. More than 189.6 million doses have been administered and more than 120.8 million Americans -- 36.4% of the total population -- have received at least one dose, with more than 74 million people, or 22.3% of the population, being fully vaccinated, according to data from the Centers for Disease Control and Prevention (CDC).
Outside of the U.S., India has replaced Brazil as the country with the second highest number of cases at 13.7 million, and is fourth globally by deaths at 171,058. Brazil is third by cases at 13.5 million and second with a death toll of 354,617. Mexico is third by deaths at 209,702 and 14th highest by cases at 2.3 million. The U.K. has 4.38 million cases and 127,346 deaths, the highest in Europe and fifth highest in the world.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
|
|
Novavax Inc. said late Tuesday that Chief Financial Officer Greg Covino is stepping down for personal reasons, but will remain connected to the company as an executive adviser. The biotech also said it promoted Gale E. Smith to chief scientist and Troy Morgan as chief compliance officer. Executive Vice President John J. Trizzino will assume the role of CFO while the company searches for a permanent replacement. Novavax said last week it will expand clinical trials of its COVID-19 vaccine candidate to include children and teens. Earlier this year, the company said it hoped to get an emergency-use authorization from the FDA for its vaccine candidate in May. Shares of Novavax fell 0.9% in the extended session Tuesday after the stock rallied nearly 11% during the regular trading day.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
|
|
SAP shares were up 3% in extended trading Tuesday following preliminary first-quarter results. The German software giant reported revenue of 6.35 billion euros (about $7.6 billion), down 3% from 6.52 billion euros ($7.8 billion) in the same quarter a year ago. SAP reported a profit, after taxes, of 1.07 billion euros ($1.3 billion), up 32% from 810 million euros ($967.8 million) a year ago. "We are seeing very strong growth across all our applications" such as cloud and software licenses, SAP Chief Executive Christian Klein said in a statement. SAP raised its full-year 2021 outlook reflecting "strong new cloud business performance which is expected to reaccelerate cloud revenue growth." Shares of SAP are up 3% so far this year. The broader S&P 500 index has increased 10% in 2021.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
|
|
These drugmaker stocks may have been hammered down to bargain-bin prices.
|
RELATED ARTICLES | | |
|
